Reference
Alston, C. L., Compton, A. G., Formosa, L. E., Strecker, V., Oláhová,
M., Haack, T. B., . . . Taylor, R. W. (2016). Biallelic Mutations in
TMEM126B Cause Severe Complex I Deficiency with a Variable Clinical
Phenotype. Am J Hum Genet , 99 (1), 217-227.
https://doi.org/10.1016/j.ajhg.2016.05.021
Beck, B. B., Baasner, A., Buescher, A., Habbig, S., Reintjes, N.,
Kemper, M. J., . . . Hoppe, B. (2013). Novel findings in patients with
primary hyperoxaluria type III and implications for advanced molecular
testing strategies. Eur J Hum Genet , 21 (2), 162-172.
https://doi.org/10.1038/ejhg.2012.139
Cartegni, L., Wang, J., Zhu, Z., Zhang, M. Q., & Krainer, A. R. (2003).
ESEfinder: A web resource to identify exonic splicing enhancers.Nucleic Acids Res , 31 (13), 3568-3571.
https://doi.org/10.1093/nar/gkg616
Darin, N., Oldfors, A., Moslemi, A. R., Holme, E., & Tulinius, M.
(2001). The incidence of mitochondrial encephalomyopathies in childhood:
clinical features and morphological, biochemical, and DNA abnormalities.Ann Neurol , 49 (3), 377-383.
Dunning, C. J., McKenzie, M., Sugiana, C., Lazarou, M., Silke, J.,
Connelly, A., . . . Ryan, M. T. (2007). Human CIA30 is involved in the
early assembly of mitochondrial complex I and mutations in its gene
cause disease. Embo j , 26 (13), 3227-3237.
https://doi.org/10.1038/sj.emboj.7601748
Fassone, E., Taanman, J.-W., Hargreaves, I. P., Sebire, N. J., Cleary,
M. A., Burch, M., & Rahman, S. (2011). Mutations in the mitochondrial
complex I assembly factor NDUFAF1 cause fatal infantile hypertrophic
cardiomyopathy. 48 (10), 691-697.
https://doi.org/10.1136/jmedgenet-2011-100340 %J Journal of
Medical Genetics
Fassone, E., Taanman, J. W., Hargreaves, I. P., Sebire, N. J., Cleary,
M. A., Burch, M., & Rahman, S. (2011). Mutations in the mitochondrial
complex I assembly factor NDUFAF1 cause fatal infantile hypertrophic
cardiomyopathy. J Med Genet , 48 (10), 691-697.
https://doi.org/10.1136/jmedgenet-2011-100340
Formosa, L. E., Dibley, M. G., Stroud, D. A., & Ryan, M. T. (2018).
Building a complex complex: Assembly of mitochondrial respiratory chain
complex I. Semin Cell Dev Biol , 76 , 154-162.
https://doi.org/10.1016/j.semcdb.2017.08.011
Gudmundsson, S., Singer-Berk, M., Watts, N. A., Phu, W., Goodrich, J.
K., Solomonson, M., . . . O’Donnell-Luria, A. (2021). Variant
interpretation using population databases: Lessons from gnomAD.Hum Mutat . https://doi.org/10.1002/humu.24309
Heide, H., Bleier, L., Steger, M., Ackermann, J., Dröse, S., Schwamb,
B., . . . Brandt, U. (2012). Complexome profiling identifies TMEM126B as
a component of the mitochondrial complex I assembly complex. Cell
Metab , 16 (4), 538-549.
https://doi.org/10.1016/j.cmet.2012.08.009
Hirst, J. (2013). Mitochondrial complex I. Annu Rev Biochem ,82 , 551-575.
https://doi.org/10.1146/annurev-biochem-070511-103700
Kobayashi, Y., Yang, S., Nykamp, K., Garcia, J., Lincoln, S. E., &
Topper, S. E. (2017). Pathogenic variant burden in the ExAC database: an
empirical approach to evaluating population data for clinical variant
interpretation. Genome Med , 9 (1), 13.
https://doi.org/10.1186/s13073-017-0403-7
Lake, N. J., Compton, A. G., Rahman, S., & Thorburn, D. R. J. A. o. n.
(2016). Leigh syndrome: one disorder, more than 75 monogenic causes.79 (2), 190-203.
Landrum, M. J., Lee, J. M., Benson, M., Brown, G. R., Chao, C.,
Chitipiralla, S., . . . Maglott, D. R. (2018). ClinVar: improving access
to variant interpretations and supporting evidence. Nucleic Acids
Res , 46 (D1), D1062-d1067.
https://doi.org/10.1093/nar/gkx1153
Lex, A., Gehlenborg, N., Strobelt, H., Vuillemot, R., & Pfister, H.
(2014). UpSet: Visualization of Intersecting Sets. IEEE Trans Vis
Comput Graph , 20 (12), 1983-1992.
https://doi.org/10.1109/tvcg.2014.2346248
Lou, X., Shi, H., Wen, S., Li, Y., Wei, X., Xie, J., . . . Lyu, J.
(2018). A Novel NDUFS3 mutation in a Chinese patient with severe Leigh
syndrome. J Hum Genet , 63 (12), 1269-1272.
https://doi.org/10.1038/s10038-018-0505-0
Mimaki, M., Wang, X., McKenzie, M., Thorburn, D. R., & Ryan, M. T.
(2012). Understanding mitochondrial complex I assembly in health and
disease. Biochim Biophys Acta , 1817 (6), 851-862.
https://doi.org/10.1016/j.bbabio.2011.08.010
Rahman, S., Blok, R. B., Dahl, H. H., Danks, D. M., Kirby, D. M., Chow,
C. W., . . . Thorburn, D. R. (1996). Leigh syndrome: clinical features
and biochemical and DNA abnormalities. Ann Neurol , 39 (3),
343-351. https://doi.org/10.1002/ana.410390311
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J.,
. . . Rehm, H. L. (2015). Standards and guidelines for the
interpretation of sequence variants: a joint consensus recommendation of
the American College of Medical Genetics and Genomics and the
Association for Molecular Pathology. Genet Med , 17 (5),
405-424. https://doi.org/10.1038/gim.2015.30
Sánchez-Caballero, L., Ruzzenente, B., Bianchi, L., Assouline, Z.,
Barcia, G., Metodiev, M. D., . . . Rötig, A. (2016). Mutations in
Complex I Assembly Factor TMEM126B Result in Muscle Weakness and
Isolated Complex I Deficiency. Am J Hum Genet , 99 (1),
208-216. https://doi.org/10.1016/j.ajhg.2016.05.022
Schapira, A. H. (1993). Mitochondrial complex I deficiency in
Parkinson’s disease. Adv Neurol , 60 , 288-291.
Schiff, M., Haberberger, B., Xia, C., Mohsen, A. W., Goetzman, E. S.,
Wang, Y., . . . Vockley, J. (2015). Complex I assembly function and
fatty acid oxidation enzyme activity of ACAD9 both contribute to disease
severity in ACAD9 deficiency. Hum Mol Genet , 24 (11),
3238-3247. https://doi.org/10.1093/hmg/ddv074
Schubert Baldo, M., & Vilarinho, L. (2020). Molecular basis of Leigh
syndrome: a current look. Orphanet J Rare Dis , 15 (1), 31.
https://doi.org/10.1186/s13023-020-1297-9
Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L.,
Smigielski, E. M., & Sirotkin, K. (2001). dbSNP: the NCBI database of
genetic variation. Nucleic Acids Res , 29 (1), 308-311.
https://doi.org/10.1093/nar/29.1.308
Stenson, P. D., Mort, M., Ball, E. V., Shaw, K., Phillips, A., &
Cooper, D. N. (2014). The Human Gene Mutation Database: building a
comprehensive mutation repository for clinical and molecular genetics,
diagnostic testing and personalized genomic medicine. Hum Genet ,133 (1), 1-9. https://doi.org/10.1007/s00439-013-1358-4
Theunissen, T. E. J., Gerards, M., Hellebrekers, D., van Tienen, F. H.,
Kamps, R., Sallevelt, S., . . . Smeets, H. J. M. (2017). Selection and
Characterization of Palmitic Acid Responsive Patients with an OXPHOS
Complex I Defect. Front Mol Neurosci , 10 , 336.
https://doi.org/10.3389/fnmol.2017.00336
Tinker, R. J., Lim, A. Z., Stefanetti, R. J., & McFarland, R. (2021).
Current and Emerging Clinical Treatment in Mitochondrial Disease.Mol Diagn Ther , 25 (2), 181-206.
https://doi.org/10.1007/s40291-020-00510-6
Volodarsky, M., Zilberman, U., & Birk, O. S. (2015). Novel FAM20A
mutation causes autosomal recessive amelogenesis imperfecta. Arch
Oral Biol , 60 (6), 919-922.
https://doi.org/10.1016/j.archoralbio.2015.02.018
Wang, M., & Marín, A. (2006). Characterization and prediction of
alternative splice sites. Gene , 366 (2), 219-227.
https://doi.org/10.1016/j.gene.2005.07.015
Wei, X., Du, M., Li, D., Wen, S., Xie, J., Li, Y., . . . Fang, H.
(2020). Mutations in FASTKD2 are associated with mitochondrial disease
with multi-OXPHOS deficiency. Hum Mutat , 41 (5), 961-972.
https://doi.org/10.1002/humu.23985
Wiel, L., Baakman, C., Gilissen, D., Veltman, J. A., Vriend, G., &
Gilissen, C. (2019). MetaDome: Pathogenicity analysis of genetic
variants through aggregation of homologous human protein domains.Hum Mutat , 40 (8), 1030-1038.
https://doi.org/10.1002/humu.23798
Zheng-Bradley, X., & Flicek, P. (2017). Applications of the 1000
Genomes Project resources. Brief Funct Genomics , 16 (3),
163-170. https://doi.org/10.1093/bfgp/elw027